Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$773K Sell
138,006
-28,256
-17% -$164K ﹤0.01% 3409
2025
Q4
$974K Buy
166,262
+89,943
+118% +$564K ﹤0.01% 3355
2025
Q3
$495K Sell
76,319
-38,342
-33% -$253K ﹤0.01% 3633
2025
Q2
$907K Buy
114,661
+10,019
+10% +$75.5K ﹤0.01% 3309
2025
Q1
$808K Sell
104,642
-40,799
-28% -$357K ﹤0.01% 3290
2024
Q4
$1.49M Sell
145,441
-89
-0.1% -$831 ﹤0.01% 3066
2024
Q3
$1.34M Sell
145,530
-235
-0.2% -$1.93K ﹤0.01% 3094
2024
Q2
$1.2M Sell
145,765
-83,187
-36% -$786K ﹤0.01% 3084
2024
Q1
$2.76M Buy
228,952
+24,194
+12% +$266K ﹤0.01% 2706
2023
Q4
$2.26M Buy
204,758
+13,280
+7% +$128K ﹤0.01% 2807
2023
Q3
$1.89M Sell
191,478
-17,688
-8% -$209K ﹤0.01% 2841
2023
Q2
$2.75M Sell
209,166
-1,100,693
-84% -$11.9M ﹤0.01% 2718
2023
Q1
$14.3M Sell
1,309,859
-1,833,583
-58% -$19.1M ﹤0.01% 1495
2022
Q4
$27.1M Buy
+3,143,442
New +$36M 0.01% 1037

Other funds holding XPER

Ameriprise's XPER Position: Q1 2026 in Review

Ameriprise reduced its Xperi (XPER) stake by 17% in Q1 2026, selling an estimated $164K and leaving 138,006 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Ameriprise first reported a position in XPER in Q4 2022 and has held it in 14 quarters since. The position peaked at $27.1M in Q4 2022. 141 funds tracked by Wall St. Rank hold XPER as of Q1 2026.

  • Ameriprise held 138,006 shares of Xperi worth $773K as of Q1 2026.
  • Ameriprise sold 28,256 Xperi shares in Q1 2026, an estimated $164K.
  • Xperi made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3409 holding.
  • Ameriprise first reported a position in Xperi in Q4 2022 and has held it in 14 quarters since.
  • Ameriprise's Xperi position peaked at $27.1M in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Xperi as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.